Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NYSE:ABBV
AbbVie
|
160.45 | -20.2% | -9.65% | 283,333.49 | 3.81% | 7.03% |
|
NasdaqGS:AMGN
Amgen
|
307.31 | -10.78% | -1.85% | 164,851.75 | 3% | 5.31% |
|
NasdaqGS:GILD
Gilead Sciences Inc
|
64.92 | 26.11% | 35.77% | 80,953.25 | 4.71% | 0.15% |
|
NasdaqGM:ALXN
Alexion Pharmaceuticals
|
182.50 | 0% | 0% | 40,336.01 | 0% | 0% |
|
NasdaqGS:BIIB
Biogen
|
219.72 | -11.04% | 4.75% | 31,990.55 | 0% | -10.89% |
|
NasdaqGS:BMRN
BioMarin Pharmaceutical
|
81.83 | 139.83% | 218.47% | 15,537.86 | 0% | 32.46% |
|
NasdaqGS:INCY
Incyte
|
53.51 | 104.78% | 153.24% | 12,015.18 | 0% | 27.62% |
|
NasdaqCM:VKTX
Viking Therapeutics
|
79.91 | 0% | 0% | 8,811.53 | 0% | 0% |
|
NasdaqGS:BPMC
Blueprint Medicines
|
108.78 | 0% | 0% | 6,811.47 | 0% | 0% |
|
NasdaqGM:ARNA
Arena Pharmaceuticals
|
99.99 | 0% | 0% | 6,165.32 | 0% | 0% |
|
NasdaqGM:IOVA
Iovance Biotherapeutics
|
13.39 | 0% | 0% | 3,746.95 | 0% | 0% |
|
NasdaqGS:CCXI
ChemoCentryx
|
51.99 | 0% | 0% | 3,739.11 | 0% | 0% |
|
NasdaqGS:CBAY
CymaBay Therapeutics
|
32.44 | 0% | 0% | 3,724.47 | 0% | 0% |
|
NasdaqGS:ARWR
Arrowhead Pharmaceuticals
|
25.22 | 0% | 0% | 2,989.63 | 0% | 0% |
|
NasdaqGM:DRNA
Dicerna Pharmaceuticals
|
38.01 | 0% | 0% | 2,986.1 | 0% | 0% |
|
NasdaqGM:FOLD
Amicus Therapeutics
|
10.14 | 0% | 0% | 2,958.8 | 0% | 0% |
|
NasdaqGS:ACAD
ACADIA Pharmaceuticals
|
17.13 | 0% | 0% | 2,829.94 | 0% | 0% |
|
NasdaqCM:CLDX
Celldex Therapeutics
|
41.21 | 0% | 0% | 2,805.15 | 0% | 0% |
|
NasdaqGM:VCEL
Vericel
|
47.69 | -94.68% | -75.67% | 2,302.96 | 0% | 0% |
|
NasdaqGM:ARDX
Ardelyx
|
8.48 | 0% | 0% | 2,040.28 | 0% | 0% |
